CVM

CEL-SCI Corporation (CVM) is a pioneering biotechnology firm based in Vienna, Virginia, specializing in immunotherapy solutions for cancer and infectious diseases. The company's flagship product candidate, Multikine, is designed to leverage the immune system to effectively target and eliminate tumors, positioning CEL-SCI at the forefront of cancer treatment innovation. With a strong pipeline and a focus on addressing significant unmet medical needs, CEL-SCI is poised to make impactful strides in the biopharmaceutical landscape, appealing to institutional investors seeking opportunities in advancing healthcare solutions.